Dr. Jeremy Scott Kroes, MD

Dr. Kroes practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Kroes' NPI, 1841233715, was assigned on June 14, 2006. Dr. Kroes graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1999. Dr. Kroes holds California license A74428.

Dr. Kroes' primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Kroes' primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health, Fountain Valley Emergency Department.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kroes practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Kroes' primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Kroes is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Kroes' licenses on file in 3 states: California, Texas and Illinois.

CMS data shows 578 Medicare services from Dr. Kroes across 4 procedure codes in 2024, for 430 Medicare patients. Medicare paid $61,126 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 430 Medicare patients who saw Dr. Kroes in 2024. The largest group is 75 to 84, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 83% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kroes' median patient age at 52, with 54% women.

In 2024, Dr. Kroes wrote 202 Medicare Part D claims for 128 patients. 95% of them were for generic drugs. CMS names the drug for 78 of them, across 4 drugs with 11 or more claims each, at $510 in total drug cost. In 2023, CMS named 64 claims across 5 drugs.

Dr. Kroes accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Kroes to 1 clinical trial. Conditions studied include Cerebral Hemorrhage and Intracranial Hemorrhages.

CMS Open Payments shows 13 general payments to Dr. Kroes from 4 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 94% of the total. Revance Therapeutics, Inc. paid the most, $306.

Dr. Kroes graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1999.

Dr. Kroes is in network with 2 carriers, including CMS Medicare and GA State Medicaid. Medicaid plans come from the most carriers, 1. Check the plan with the practice before a visit.